Preliminary data on the pharmacodynamic properties of methoxy-3-dalbergine (neoflavonoid)
Gábor, M.; Magyarlaki, A.B.
Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(1): 36-42
1970
ISSN/ISBN: 0037-9026 PMID: 4248281 Document Number: 27683
Document emailed within 1 workday
Related Documents
Vinnikova, A.N.; Utkina, N.S.; Danilov, L.L.; Torgov, V.I.; Druzhinina, T.N.; Veselovskiĭ, V.V. 2013: Synthesis and acceptor properties of 11-[(9'-anthracenyl)methoxy]undecyl phosphate and P1-{11-[(9'-anthracenyl)methoxy]undecyl}-P2-(alpha-D-galactopyranosyl) diphosphate in the enzymic reactions catalyzed by galactosylphosphotransferase and mannosyltransferase from Salmonella newport Bioorganicheskaia Khimiia 39(1): 99-104Isaeva, G.M.; Beĭsembaeva, R.U. 1993: Estradiol-binding properties of a sheep haptoglobin complex with hemoglobin. II. Preliminary data on quantitative characteristics of interaction Biokhimiia 58(5): 700-706
Langnickel, R.; Bluth, R. 1985: Pharmacokinetic properties and indications for modern vasodilators. 1. Pharmacodynamic properties of vasodilators Zeitschrift für Arztliche Fortbildung 79(19): 821-825
Adam, D.; Heinzl, S. 1989: Oral penicillins. Pharmacodynamic and pharmacokinetic properties Medizinische Monatsschrift für Pharmazeuten 12(4): 117-122
Bergogne-Bérézin, E. 1997: Fluoroquinolones. Pharmacokinetic properties and new pharmacodynamic concepts Presse Medicale 26(12): 577-582
Muir, W.W.; Sams, R.A.; Huffman, R.H.; Noonan, J.S. 1982: Pharmacodynamic and pharmacokinetic properties of diazepam in horses American Journal of Veterinary Research 43(10): 1756-1762
Forbes, L.S. 1972: Pharmacodynamic actions of diethylcarbamazine in the dog with particular reference to nicotine-like properties Southeast Asian Journal of Tropical Medicine and Public Health 3(1): 93-98
Weidinger, G. 1995: Pharmacokinetic and pharmacodynamic properties and therapeutic use of bunazosin in hypertension. A review Arzneimittel-Forschung 45(11): 1166-1171
Palmer, G.C.; Murray, R.J.; Cramer, C.L.; Stagnitto, M.L.; Knowles, M.K.; Freedman, L.R.; Eismann, M.S.; Mahmood, N.; Balestra, M.; Borrelli, A.R.; Hudzik, T.J.; McCarthy, D.J. 1999: S]-AR-R 15896AR-A novel anticonvulsant: acute safety, pharmacokinetic and pharmacodynamic properties Journal of Pharmacology and Experimental Therapeutics 288(1): 121-132
Brogden, R.N.; Buckley, M.M.; Ward, A. 1990: Buserelin. a review of its pharmacodynamic and pharmacokinetic properties, and clinical profile Drugs 39(3): 399-437
Orzechowska-Juzwenko, K. 1998: Optimizing pharmacotherapeutic aspects of pharmacokinetic and pharmacodynamic drug properties in the elderly Przeglad Lekarski 55(11): 607-610
Bonacchi, G.; Agostini, O.; Fedi, M.; Bacciarelli, C.; Boni, P.; Castellucci, A.; Perretti, F.; Manzini, S. 1988: Resolution and pharmacological properties of the enantiomers of the potent alpha-adrenoceptor antagonist 1-[2-ethoxy-2-(3'-pyridyl)ethyl]-4-(2'-methoxy-phenyl)piperazine Arzneimittel-Forschung 38(5): 650-654
Fotherby, K.; Saxena, B.N.; Shrimanker, K.; Hingorani, V.; Takker, D.; Diczfalusy, E.; Landgren, B.M. 1980: A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate Fertility and Sterility 34(2): 131-139
Breithaupt-Grögler, K.; Malerczyk, C.; Belz, G.G.; Butzer, R.; Herrmann, V.; Stass, H.; Wensing, G. 1997: Pharmacodynamic and pharmacokinetic properties of an angiotensin Ii receptor antagonist--characterization by use of Schild regression technique in man International Journal of Clinical Pharmacology and Therapeutics 35(10): 434-441
Albert, O.; Dupont, M.; Quirin, M. 1970: Studies on some pharmacodynamic properties of an indole alkaloid: dregamine. Action on the nervous and muscular systems Annales Pharmaceutiques Francaises 28(12): 697-706
Nivière, P.; Didier, F.; Ernouf, G. 1973: Synthesis and study of pharmacodynamic properties of several benzo-gamma-pyronic amides halogenated in the nucleus Annales Pharmaceutiques Francaises 31(4): 313-320
LaBrosse, E.H.; Com-Nougué, C.; Zucker, J.M.; Comoy, E.; Bohuon, C.; Lemerle, J.; Schweisguth, O. 1980: Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors Cancer Research 40(6): 1995-2001
Il'iuchenok, T.Iu.; Matveeva, I.A.; Budagov, R.O. 1987: Changes in the pharmacodynamic properties of promedol, droperidol and dimedrol in burn shock and combined radiation-thermal injury Farmakologiia i Toksikologiia 50(1): 71-74
Sotnikov, V.S.; Utkin, D.V.; Obodan, L.Z.; Smirnov, V.V. 1977: Preparation of glycerin solutions for intravenous administration. III. the pharmacodynamic properties of a glycerin solution Farmatsevtychnyi Zhurnal 6: 56-61
Feldman, A.M. 1982: Wage and salary data from the Income Survey Development Program: 1979, (preliminary data from Interview Period One) Current Population Reports. Series P-20 Population Characteristics 1982(118): 1-49